Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BIO Teams With Zerhouni On Quest For "New Big Ideas" To Speed Development

Executive Summary

BIO CEO Jim Greenwood is looking for "new big ideas" that would enable the pharmaceutical industry "to accelerate the pace of progress from academic research and translational research into products.

You may also be interested in...



BIO Creating "Game-Changing" Legislative Proposal To Boost R&D

BIO's blueprint for an economic and regulatory environment that facilitates innovation in biotechnology and the industry's ability to bring products to market could be finished within a few months.

BIO Creating "Game-Changing" Legislative Proposal To Boost R&D

BIO's blueprint for an economic and regulatory environment that facilitates innovation in biotechnology and the industry's ability to bring products to market could be finished within a few months.

Next Up, Parkinson's: Coalition Against Major Diseases Moves To Link Neurodegenerative Ailments In Database

Following the creation of an Alzheimer's disease database, firms will submit control trial data help develop Parkinson's and Huntington's biomarkers as well.

Related Content

Topics

UsernamePublicRestriction

Register

PS052574

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel